Humana  logo
Humana HUM
$ 363.86 -0.76%
report update icon

Annual report 2025
added 07-29-2026

Humana Cash Flow 2025-2006 | HUM

Brief overview of Humana 's cash flow quality

This overview follows the five latest available annual observations in the 2021–2025 interval.

Core cash generation deteriorated, ending at $921 million versus $2.3 billion at the beginning.

Core operations generated cash in every available annual observation. Stability was high.

Across five periods, operating cash flow equaled about 1.39x of cumulative net income. Earnings were strongly backed by cash.

Operating cash flow margin changed only slightly, from 2.7% to 0.7%.

Overall picture

Humana retains acceptable cash resilience. Future assessment depends on cash margin, capex and debt trends.

Annual Cash Flow Humana

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006

Operating Cash Flow

921 M 2.97 B 3.98 B 4.59 B 2.26 B 5.64 B 5.28 B 2.17 B 4.05 B 1.94 B 868 M 1.62 B 1.72 B 1.92 B 2.08 B 2.24 B 1.42 B 982 M 1.22 B -

Depreciation & Amortization

698 M 839 M 779 M 709 M 596 M 528 M 505 M 444 M 410 M 388 M 354 M 449 M 426 M 338 M 303 M 263 M 250 M 220 M 185 M -

Accounts Receivables

3.27 B 2.7 B 2.04 B 1.67 B 1.81 B 1.14 B 1.06 B 1.02 B 854 M 1.28 B 1.16 B 1.17 B 950 M 733 M 1.03 B 959 M 824 M - - -

All numbers in USD currency

Quarterly Cash Flow Humana

2026-Q1 2025-Q3 2025-Q2 2025-Q1 2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1 2010-Q3 2010-Q2 2010-Q1 2009-Q3 2009-Q2

Operating Cash Flow

1.25 B - - 331 M - - 423 M - - 6.69 B - 9.71 B - 302 M - 2.36 B - -837 M - 5.36 B 3.54 B 474 M - 4.77 B 2.33 B 896 M - 2.51 B 3.56 B 3.69 B - 6.96 B 4.1 B 4.2 B - 4.71 B 206 M 502 M - 531 M -501 M 107 M - 1.42 B 471 M 671 M - 1.73 B - 412 M - 1.72 B 3.05 B 2.35 B - 3.88 B 957 M 796 M 2.29 B 1.08 B 755 M 1.15 B 207 M

Depreciation & Amortization

163 M 173 M 178 M 183 M 210 M 212 M 209 M 201 M 191 M 186 M - 25 M 18 M 181 M - 468 M 15 M 153 M - 390 M 252 M 124 M - 382 M 240 M 118 M - 330 M 218 M 109 M - 303 M 201 M 100 M - 289 M 190 M 94 M - 263 M 178 M 88 M - 240 M 157 M 79 M - 312 M 206 M 102 M - 238 M 160 M 78 M - 225 M 151 M 76 M 64.6 M 69.3 M 62.8 M 62.1 M 60.5 M

Accounts Receivables

5.22 B 2.68 B 4.5 B 4.46 B 2.14 B 4.09 B 3.92 B 1.82 B 1.43 B 3.11 B 1.67 B 1.61 B - 3.17 B 1.81 B 1.88 B 2.44 B 2.2 B 1.14 B 1.14 B 1.14 B 1.14 B 1.06 B 1.06 B 1.06 B 1.06 B 1.02 B 1.02 B 1.02 B 1.02 B 854 M 854 M 854 M 854 M 1.28 B 1.28 B 1.28 B 1.28 B 1.16 B 1.16 B 1.16 B 1.16 B 1.05 B 1.05 B 1.05 B 1.05 B 950 M 950 M 950 M 950 M 733 M 733 M 733 M 733 M 1.03 B 1.03 B 1.03 B 1.03 B - - - - -

All numbers in USD currency

Cash Flow Statement is one of the three key financial reports of the company Humana , reflecting the actual cash inflows and outflows over a certain period. Unlike the income statement, which shows revenues and expenses on an accrual basis, the cash flow statement focuses on real cash flows — how much cash actually came into the company and how much was spent.

Main Sections of the Cash Flow Statement
  • Operating Activities
    This section reflects cash flows related to the company’s core operations: receipts from sales of goods and services, payments to suppliers, employee salaries, taxes, and other operating expenses. Positive cash flow from operating activities indicates the viability of the business and its ability to generate cash.
  • Investing Activities
    Shows cash movements related to the purchase and sale of long-term assets such as real estate, equipment, and investments in other companies. Negative cash flow here often indicates investments in growth, which can be a positive sign.
  • Financing Activities
    Reflects the inflow and outflow of cash related to raising and repaying capital: issuing shares, loans, dividend payments, and loan repayments. This section shows how the company finances its activities and distributes profits.

The cash flow statement is important for investors because it allows them to assess the company’s real liquidity, showing whether it has enough cash to cover current obligations and investments — this is critical for financial stability. Additionally, it helps analyze the quality of earnings, since profits reported in the income statement can be "paper" profits and may not reflect actual cash inflows; the cash flow statement reveals this difference. The presence of free cash is also crucial for evaluating the company’s ability to finance growth and pay dividends, which is important for investors. Attention should also be paid to prolonged negative cash flows from operating activities, as this may serve as a warning sign of potential problems with the core business.

Cash flow statements of other stocks in the Health care sector

Issuer Price % 24h Market Cap Country
Anthem Anthem
ANTM
- -2.32 % $ 107 B usaUSA
NovoCure Limited NovoCure Limited
NVCR
$ 14.84 -2.56 % $ 1.65 B jerseyJersey
Molina Healthcare Molina Healthcare
MOH
$ 195.62 0.47 % $ 10.3 B usaUSA
Centene Corporation Centene Corporation
CNC
$ 62.22 2.32 % $ 30.7 B usaUSA
CVS Health Corporation CVS Health Corporation
CVS
$ 104.43 -0.65 % $ 132 B usaUSA
Cigna Corporation Cigna Corporation
CI
$ 279.05 -3.0 % $ 73.5 B usaUSA
UnitedHealth Group Inc. UnitedHealth Group Inc.
UNH
$ 414.4 -1.68 % $ 376 B usaUSA